Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Active, not recruiting Not applicable

A School Program for Teenagers to Promote Positive Body Image Using Social Media Education and Self-Compassion-Based Activities

NCT07103213 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-09-09
Last updated
2025-08-05

Condition(s) studied

Body Esteem

Investigational drug(s) / intervention(s)

IMPACTREEL programme

IMPACTREEL programme: The IMPACTREEL programme is a school-based intervention designed to promote positive body image in adolescents. It combines social media literacy education with third-wave strategies, including mindfulness, self-compassion, and psychological flexibility. The intervention consists of 7 weekly group sessions lasting 55 minutes each, delivered by trained psychologists facilitators during school hours. The content targets appearance ideal internalisation, critical thinking about social media, and healthier body image attitudes.

Study summary

Background and study aims Many teenagers feel unhappy with their bodies, which can lead to problems like eating disorders, low self-esteem, and depression. Social media plays an important role in shaping how young people see themselves, often promoting unrealistic beauty standards. This study aims to test the effectiveness of a school-based programme called IMPACTREEL, which teaches adolescents how to critically understand social media and improve their relationship with their body using strategies from third-wave psychological therapies. The goal is to help teenagers feel better about their bodies and reduce the risks of developing mental health problems.

Who can participate? The study is open to first year high-school adolescents who attend selected secondary schools in the province of Alicante (Spain). Participation is voluntary, and both the students and their parents/legal guardians must give consent to take part. Young people showing severe symptoms of eating disorders will not be included, as they may need clinical treatment.

What does the study involve?

Participants will be randomly assigned by classroom to one of two groups:

The intervention group will receive the IMPACTREEL programme, which consists of seven weekly sessions, each lasting 55 minutes, delivered at school by trained facilitators.

The control group will not receive the programme during the study but will be offered it later.

Both groups will be asked to complete a series of questionnaires about body image, social media use, emotional well-being, and quality of life before the programme, after it ends, and again 6 months and 12 months later. These questionnaires are confidential and anonymous.

What are the possible benefits and risks of participating? Participants in the intervention group may learn new skills to help them manage how they feel about their body and how they use social media. These strategies may also help reduce stress and improve emotional well-being.

There are no known risks of taking part in this study. Completing the questionnaires or discussing body image may make some students feel uncomfortable, but they are free to stop participating at any time. No clinical diagnosis or treatment is involved in this study.

Where is the study run from? The study is being run by psychologists and researchers from the Universidad Miguel Hernández de Elche (Spain), in collaboration with local secondary schools in the province of Alicante.

When is the study starting and how long is it expected to run for? The study started in 2024 and is expected to continue until 2028, including follow-up assessments and data analysis.

Who is funding the study? The study is funded by a FPU (Formación del Profesorado Universitario) grant from the Spanish Ministry of Universities, which supports doctoral training and research.

Who is the main contact?

Main contact:

Sheila Fernández García Email: sheila.fernandezg@umh.es Affiliation: Universidad Miguel Hernández de Elche

Eligibility

Sex
ALL
Min age
11 Years
Max age
14 Years
Healthy volunteers
Accepted
Inclusion Criteria: \- Firts year of high-school. Exclusion Criteria: \- Presence of severe symptoms of eating disorders, indicated by a score above 20 on the EAT-26

Primary outcome measure(s)

  • Change in body esteem — Baseline, post-intervention (week 9), 6-month follow-up, and 12-month follow-up
    Body esteem will be assessed using one validated questionnaire: the Body Esteem Scale for Adolescents and Adults (BESAA). This tool assesses self-perception and satisfaction with one's own body appearance, weight, and attribution by others. Body self-esteem measures a person's satisfaction or dissatisfaction with his or her own body. The positive appearance and negative appearance subscales assess overall satisfaction or dissatisfaction with physical appearance, including various visual aspects without focusing on a specific ideal. An example item is: "I like the way I look in pictures". The third subscale, weight, focuses on the person's satisfaction with his or her own weight, as in the item: "I am satisfied with my weight". The higher the score, the higher the body esteem. The range of scores is from 18 to 90.

Trial sites (1)

FacilityCityRegionStatus
Universidad Miguel Hernández de Elche Elche Alicante
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07103213 on ClinicalTrials.gov ↗ ← All trials in Spain